Biocogniv

AI-powered diagnostic tools that analyze routine blood tests already performed at hospitals to detect and predict acute conditions like sepsis up to 24 hours before they become clinically evident.

The company has processed 16 million+ patient encounters and 1 billion+ lab results, and received FDA Breakthrough Designation for their Sepsis aiMarker™ product.